Litcius/Paper detail

SMFM Statement: Use of 17-alpha hydroxyprogesterone caproate for prevention of recurrent preterm birth

Unknown author

2020American Journal of Obstetrics and Gynecology30 citationsDOIOpen Access PDF

Topics & Concepts

MedicineMaternal-fetal medicineGestationObstetricsSingletonPopulationGynecologyPregnancyPediatricsEnvironmental healthObstetrics and gynaecologyGeneticsBiologyPreterm Birth and ChorioamnionitisPregnancy-related medical researchEctopic Pregnancy Diagnosis and Management
SMFM Statement: Use of 17-alpha hydroxyprogesterone caproate for prevention of recurrent preterm birth | Litcius